Outpatient Addiction Recovery Services

What Outpatient Addiction Recovery Services does

Outpatient Addiction Recovery Services (OARS) is a privately held, founder-owned (Dr. Bryan Negrini) outpatient addiction treatment practice headquartered in Aliquippa, Pennsylvania, founded in 2015. The company delivers Medication-Assisted Treatment (MAT) for opioid use disorder and other substance use disorders, anchored by FDA-approved monthly buprenorphine injections (SUBLOCADE and BRIXADI) and supplemented by proprietary clinical protocols — the OARS Bucket Philosophy and OARS Weaning Protocol — along with DDAP-licensed counseling, mental health support, family and social work services, and a specialized Kratom/7-OH addiction program. OARS has conducted over 150,000 patient visits since inception and reports 91% six-month and 79% one-year retention rates.

OARS operates six physical clinic locations across western Pennsylvania (Aliquippa, Butler, New Castle, Washington, Pittsburgh-Mt. Washington, and Carmichaels) with eight additional locations announced in Hermitage, Kittanning, Cranberry, New Kensington, Monroeville, Greensburg, Uniontown, and Waynesburg. The company's go-to-market combines direct-to-consumer outreach (a centralized phone number and walk-in clinics) with a B2B referral pipeline from first responders, emergency departments, inpatient detox and rehabilitation programs, halfway houses, drug courts, and corrections departments. No external institutional funding, no M&A activity, and no public revenue figures are disclosed.

The business model is fee-for-service healthcare revenue: the practice accepts all major health insurance plans as its primary payment source, and uninsured patients pay a subscription-style self-pay rate of $200 per month or $50 per week. With 1–10 employees and a growing clinic footprint, OARS is a small, operationally focused regional provider in a state — Pennsylvania — among the most heavily impacted by the opioid epidemic.

Name

Outpatient Addiction Recovery Services

Legal name

Outpatient Addiction Recovery Services

Website

https://oarsmat.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Outpatient Addiction Recovery Services (OARS) is a founder-owned Pennsylvania outpatient addiction treatment practice providing medication-assisted treatment — primarily monthly buprenorphine injections — for opioid and other substance use disorders across six western Pennsylvania clinics, with eight more locations planned.

Ownership category

akta.pro rank

Product category

Outpatient Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG)

akta.pro secondary industries

Substance Use Recovery & Harm Reduction Support Services (BPAGAEAO), Peer Support, Recovery Coaching & Sober Living Services (HLAFACAN)

Keywords

• Outpatient addiction treatment
• Medication assisted treatment
• Substance use disorder care
• Opioid use disorder program
• Buprenorphine injection therapy

Headquarters

HQ city

Aliquippa

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Healthcare Services Revenue: OARS generates revenue through billable healthcare services including office visits, medication administration (buprenorphine injections), and counseling services. The practice accepts all major health insurance plans, treating them as the primary payment source. For uninsured patients, self-pay options are available at $200 per month or $50 weekly payments.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Outpatient Addiction Recovery Services (OARS) is a western Pennsylvania outpatient addiction treatment practice that delivers Medication Assisted Treatment (MAT) for opioid use disorder and other substance use disorders. Its core offering centers on FDA-approved monthly buprenorphine injections (SUBLOCADE and BRIXADI) combined with DDAP-licensed counseling, mental and physical health coordination, family and social support, and the proprietary OARS Bucket Philosophy and OARS Weaning Protocol, delivered across six in-person clinic locations.

Product overview

Outpatient Addiction Recovery Services (OARS) offers a unified outpatient treatment platform focused on Medication Assisted Treatment (MAT) for Opioid Use Disorder and other substance use disorders. The core offerings include FDA-approved monthly Buprenorphine injections (SUBLOCADE® and BRIXADI®) as the primary pharmacological intervention, complemented by proprietary protocols (Bucket Philosophy and Weaning Protocol), specialized programs for Kratom/7-OH addiction, and DDAP-licensed counseling services. The treatment approach integrates medication management with mental health support, family supports, social supports, physical health care, and counseling to address the multifaceted nature of addiction recovery.

Differentiator

Problem solved

Functional benefit

Products and services

• Medication Assisted Treatment (MAT) Program Evidence-based outpatient treatment program combining FDA-approved medications (including monthly buprenorphine injections) with counseling and behavioral therapies for opioid use disorder and other substance use disorders, delivered at OARS' western Pennsylvania clinics.
• Substance Use Disorder Treatment Programs
• SUBLOCADE Monthly Buprenorphine Injection FDA-approved once-a-month buprenorphine injection administered as part of OARS' Medication Assisted Treatment for adult patients with Opioid Use Disorder.
• BRIXADI Monthly Buprenorphine Injection FDA-approved monthly buprenorphine injection alternative administered as part of OARS' Medication Assisted Treatment for adult patients with Opioid Use Disorder.
• Kratom and 7-OH Addiction Treatment Program Specialized outpatient program to help patients overcome Kratom and 7-OH dependency and manage withdrawal symptoms, offered at OARS' western Pennsylvania clinics.
• DDAP-Licensed Counseling Services DDAP-licensed counseling services required as part of OARS' recovery model, delivered at multiple clinic locations to support adult patients in substance use disorder recovery.

Quantifiable outcome

• 91% 6-month patient retention rate
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• First ResponderscoreStrategic or Co-development PartnerOARS partners with first responders to coordinate care for patients with substance use disorders, ensuring seamless transitions from emergency situations to ongoing treatment programs.
• Emergency DepartmentscoreStrategic or Co-development PartnerPartnership with hospital emergency departments to facilitate immediate referrals and care coordination for patients presenting with opioid and other substance use disorders.
• Inpatient Detox and Rehabilitation ProgramscoreStrategic or Co-development PartnerCollaborative relationships with inpatient detox and rehabilitation programs for comprehensive continuum of care, ensuring patients receive appropriate levels of treatment.
• Halfway Houses and Three-Quarter HousesminorStrategic or Co-development PartnerPartnership with transitional housing facilities to support patients in recovery with stable housing while continuing outpatient treatment.
• Drug CourtscoreStrategic or Co-development PartnerFormal partnerships with drug courts for court-mandated addiction treatment services, providing an alternative to incarceration for eligible individuals.
• Corrections DepartmentscoreStrategic or Co-development PartnerCollaboration with corrections departments to provide addiction treatment services for incarcerated and recently released individuals.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BrightView Health: BrightView is a large outpatient addiction treatment provider offering MAT, counseling, and case management across multiple states, directly comparable to OARS in service mix and patient population.
• CleanSlate Centers: CleanSlate operates a multi-state network of outpatient MAT clinics using buprenorphine and other medications, directly competing with OARS in the office-based opioid treatment model.
• AppleGate Recovery: AppleGate Recovery runs office-based opioid treatment programs using buprenorphine, with a similar outpatient MAT model and patient focus to OARS.

Emerging players

• Eleanor Health: Eleanor Health provides outpatient addiction and mental health treatment with a hybrid in-person and virtual model, offering comparable MAT and counseling services with a more technology-enabled delivery model.
• Workit Health: Workit Health offers telehealth-based MAT and counseling for opioid and alcohol use disorder, competing for the same patients as OARS but through a virtual, direct-to-consumer model.
• Boulder Care: Boulder Care is a telehealth provider of medication-assisted treatment for opioid use disorder, representing an emerging model that could draw patients away from brick-and-mortar clinics like OARS.

Broad incumbents

• Acadia Healthcare: Acadia is a large behavioral health operator with a national footprint that includes substance use treatment programs, providing broader scale competition and a potential acquirer for OARS.
• Universal Health Services: UHS operates a broad network of behavioral health hospitals and outpatient facilities, including addiction treatment, making it both a competitor and a potential strategic acquirer in the SUD space.

Regional players

• Pyramid Healthcare: Pyramid Healthcare provides outpatient and residential addiction treatment across Pennsylvania, including MAT services, and competes for the same referral channels as OARS.
• Gateway Rehab: Gateway Rehab is a western Pennsylvania-based addiction treatment provider offering inpatient and outpatient services, overlapping directly with OARS' service territory and patient base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/OARSMAT
• LinkedInlinkedin.com/company/opioid-addiction-recovery-services

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Outpatient Addiction Recovery Services